Table 2.
Potential diagnostic miRNAs for ovarian cancer
| Tumor histology | Sample | Elevated miRNA | Decreased miRNA | Control | References |
|---|---|---|---|---|---|
| SAC | Serum | miR-21, miR-92, miR-93, miR-126, miR-29b | miR-155, miR-127, miR-99b | HC | [34], 2009 |
| SAC | Whole blood | miR-30c-1-3p | miR-181a-3p, miR-342-3p, miR-450-5p | HC | [35], 2010 |
| SAC | Serum | miR-132, miR-26a, let-7b, miR-145 | HC | [36], 2013 | |
| SAC, MAC | Plasma | miR-205 | let-7f | HC | [37], 2013 |
| SAC, other | Serum | miR-221 | HC | [38], 2013 | |
| MAC | Serum | miR-200a, miR-200b, miR-200c | HC | [39], 2015 | |
| SAC, MAC, CAC, EAC, mixed | Serum | miR-145 | HC | [40], 2015 | |
| SAC, MAC, CAC, EAC, other | Serum | miR-200c, miR-141 | HC | [41], 2015 |
SAC: Serous adenocarcinoma; CAC: Clear cell adenocarcinoma; EAC: Endometrioid adenocarcinoma; MAC: Mucinous adenocarcinoma; HC: Healthy control; miRNAs: MicroRNAs.